Literature DB >> 12806207

Central regulators of food intake.

Maralyn Druce1, Stephen R Bloom.   

Abstract

PURPOSE OF REVIEW: Obesity is a major public health problem and is associated with significant morbidity and mortality from coronary heart disease and type 2 diabetes. The population is becoming increasingly obese, yet for individuals weight is regulated within a narrow range. This regulation depends on the balance between energy intake (in the form of food) and energy expenditure. Thus in order to regulate weight and energy stores, the body must be able to control food intake accurately. Recently there has been a remarkable increase in our understanding of the molecular mechanisms regulating food intake and energy homeostasis. RECENT
FINDINGS: There is increased understanding of the central pathways by which known neurotransmitters affect food intake. These include peptides expressed in hypothalamic nuclei, but other brain regions including brain stem, amygdala and nucleus accumbens, are also important. Further central transmitters have been identified, such as that encoded by the gene identified in mice with the mahoganoid mutation, and roles for known transmitters have been elucidated, such as endocannabinoids and acetylcholine. There is new evidence regarding peripheral modulation of these pathways including the role of ghrelin as an initiator of feeding, and peptide YY as a medium-term satiety signal.
SUMMARY: Complex central circuitry controls food intake and energy expenditure. Circulating factors that modulate these pathways have appetite stimulation or satiety effects. These are potentially important targets for therapy in obesity. Single-gene models of obesity in animals are important in understanding these pathways, however human clinical correlates for genetically determined obesity are uncommon.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806207     DOI: 10.1097/01.mco.0000078996.96795.4a

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  9 in total

Review 1.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

2.  Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers.

Authors:  Feryal Karaca; Cigdem Usul Afsar; Meral Gunaldi; Erkut Erkurt; Vehbi Ercolak; Yasar Sertdemir; Semra Paydas
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.

Authors:  I Chapman; B Parker; S Doran; C Feinle-Bisset; J Wishart; S Strobel; Y Wang; C Burns; C Lush; C Weyer; M Horowitz
Journal:  Diabetologia       Date:  2005-04-21       Impact factor: 10.122

Review 4.  Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology.

Authors:  Dominique Bataille
Journal:  J Mol Med (Berl)       Date:  2007-03-14       Impact factor: 4.599

5.  Chronic mild stressors and diet affect gene expression differently in male and female rats.

Authors:  Shuwen Liang; Donna M Byers; Louis N Irwin
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

6.  A 9-year-old male with a duplication of chromosome 3p25.3p26.2: clinical report and gene expression analysis.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Majed Dasouki; Joan H M Knoll; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2006-03-15       Impact factor: 2.802

7.  Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes.

Authors:  A Bohdjalian; B Ludvik; B Guerci; L Bresler; E Renard; D Nocca; E Karnieli; A Assalia; R Prager; G Prager
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

8.  The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).

Authors:  Longlong Tu; Zengbing Lu; Man P Ngan; Francis F Y Lam; Claudio Giuliano; Emanuela Lovati; Claudio Pietra; John A Rudd
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

9.  The association of appetite and hormones (leptin, ghrelin, and Insulin) with resting metabolic rate in overweight/ obese women: a case-control study.

Authors:  Sara Hajishizari; Hossein Imani; Sanaz Mehranfar; Mir Saeed Yekaninejad; Atieh Mirzababaei; Cain C T Clark; Khadijeh Mirzaei
Journal:  BMC Nutr       Date:  2022-04-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.